









市場行情
/
股票
/
nasdaq-wgs
/

GeneDx Holdings Corp

WGS

135.520USD

-0.570-0.42%

交易中（美東）報價延遲15分鐘

3.92B總市值

1248.80本益比TTM



GeneDx Holdings Corp

135.520

-0.570-0.42%

概覽公司財務分析

概覽

公司

財務

分析

關於 GeneDx Holdings Corp 公司

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corp簡介



公司代碼WGS

公司名稱GeneDx Holdings Corp

上市日期Sep 04, 2020

CEOStueland (Katherine A)

員工數量1000

證券類型Ordinary Share

年結日Sep 04

公司地址333 Ludlow Street

城市STAMFORD

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編06902

電話18887291206

網址https://sema4.com/

公司代碼WGS

上市日期Sep 04, 2020

CEOStueland (Katherine A)

GeneDx Holdings Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Joshua Ruch

Independent Director

223.99K

+6.12%

Dr. Emily M. Leproust, Ph.D.

Independent Director

33.16K

+63.87%

Mr. Kevin Feeley

Chief Financial Officer

4.46K

+8.26%

Mr. Keith A. Meister

Independent Director

3.58K

-82.23%

Dr. Thomas Fuchs

Director

Dr. Bryan Dechairo

Chief Operating Officer

Ms. Katherine A. Stueland

Chief Executive Officer, Director

Mr. Jason Michael Ryan, CPA

Chairman of the Board

Mr. Eli D. Casdin

Independent Director

Mr. Richard C. (Rick) Pfenniger, Jr.

Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Joshua Ruch

Independent Director

223.99K

+6.12%

Dr. Emily M. Leproust, Ph.D.

Independent Director

33.16K

+63.87%

Mr. Kevin Feeley

Chief Financial Officer

4.46K

+8.26%

Mr. Keith A. Meister

Independent Director

3.58K

-82.23%

Dr. Thomas Fuchs

Director

Dr. Bryan Dechairo

Chief Operating Officer

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Patients with third party insurance

81.10M

78.98%

Institutional customers

18.38M

17.90%

Other

2.87M

2.79%

Self pay patients

339.00K

0.33%

由於公司未披露，未能獲取相關數據

業務

地區

業務USD

名稱

營收

佔比

Patients with third party insurance

81.10M

78.98%

Institutional customers

18.38M

17.90%

Other

2.87M

2.79%

Self pay patients

339.00K

0.33%

股東統計

更新時間: 12月3日週三

持股股東

股東類型

持股股東

佔比

Corvex Management LP

10.58%

Casdin Capital, LLC

10.40%

Icahn School of Medicine at Mount Sinai

4.75%

OPKO Health Inc

4.74%

BlackRock Institutional Trust Company, N.A.

4.56%

其他

64.96%

持股股東

佔比

Corvex Management LP

10.58%

Casdin Capital, LLC

10.40%

Icahn School of Medicine at Mount Sinai

4.75%

OPKO Health Inc

4.74%

BlackRock Institutional Trust Company, N.A.

4.56%

其他

64.96%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

34.29%

Investment Advisor

31.31%

Hedge Fund

30.92%

Corporation

10.65%

Research Firm

6.78%

Individual Investor

1.68%

Pension Fund

0.76%

Bank and Trust

0.40%

Venture Capital

0.31%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

446

32.52M

112.51%

-918.42K

2025Q2

397

34.23M

119.24%

+1.02M

2025Q1

398

32.79M

115.46%

-47.86K

2024Q4

341

29.17M

104.22%

+1.72M

2024Q3

289

26.18M

97.50%

+377.48K

2024Q2

262

24.98M

95.33%

+588.25K

2024Q1

260

22.13M

86.19%

+1.41M

2023Q4

271

20.57M

80.67%

-567.28K

2023Q3

283

21.68M

85.29%

-751.02K

2023Q2

291

21.85M

86.03%

-864.88K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Corvex Management LP

3.06M

10.65%

Aug 22, 2025

Casdin Capital, LLC

3.05M

10.6%

-461.51K

-13.16%

Aug 22, 2025

Icahn School of Medicine at Mount Sinai

1.37M

4.78%

-1.35M

-49.50%

Feb 21, 2025

OPKO Health Inc

1.37M

4.77%

-800.83K

-36.88%

Nov 20, 2024

BlackRock Institutional Trust Company, N.A.

1.28M

4.45%

+241.28K

+23.25%

Jun 30, 2025

William Blair Investment Management, LLC

1.63M

5.68%

+442.41K

+37.21%

Jun 30, 2025

The Vanguard Group, Inc.

1.18M

4.09%

+148.96K

+14.50%

Jun 30, 2025

Goldman Sachs & Company, Inc.

973.26K

3.39%

-59.05K

-5.72%

Jun 30, 2025

Oracle Investment Management, Inc.

922.45K

3.21%

-47.50K

-4.90%

Jun 30, 2025

Summit Partners Public Asset Management, LLC

767.26K

2.67%

-435.26K

-36.20%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Global X Genomics & Biotechnology ETF

3.84%

Franklin Genomic Advancements ETF

3.47%

Clough Hedged Equity ETF

2.89%

Clough Select Equity ETF

2.65%

State Street SPDR S&P Health Care Services ETF

2.27%

Harbor Health Care ETF

1.85%

Innovator IBD Breakout Opportunities ETF

1.52%

ARK Genomic Revolution ETF

1.29%

Main Thematic Innovation ETF

1.29%

Invesco Dorsey Wright Healthcare Momentum ETF

1.18%

Global X Genomics & Biotechnology ETF

佔比3.84%

Franklin Genomic Advancements ETF

佔比3.47%

Clough Hedged Equity ETF

佔比2.89%

Clough Select Equity ETF

佔比2.65%

State Street SPDR S&P Health Care Services ETF

佔比2.27%

Harbor Health Care ETF

佔比1.85%

Innovator IBD Breakout Opportunities ETF

佔比1.52%

ARK Genomic Revolution ETF

佔比1.29%

Main Thematic Innovation ETF

佔比1.29%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比1.18%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

Apr 28, 2023

Merger

33→1

Apr 28, 2023

Merger

33→1

Apr 28, 2023

Merger

33→1

Apr 28, 2023

Merger

33→1

公告日期

類型

比率

Apr 28, 2023

Merger

33→1

Apr 28, 2023

Merger

33→1

Apr 28, 2023

Merger

33→1

Apr 28, 2023

Merger

33→1

常見問題

GeneDx Holdings Corp的前五大股東是誰？



GeneDx Holdings Corp的前五大股東如下：
Corvex Management LP
持有股份：3.06M
佔總股份比例：10.65%。
Casdin Capital, LLC
持有股份：3.05M
佔總股份比例：10.60%。
Icahn School of Medicine at Mount Sinai
持有股份：1.37M
佔總股份比例：4.78%。
OPKO Health Inc
持有股份：1.37M
佔總股份比例：4.77%。
BlackRock Institutional Trust Company, N.A.
持有股份：1.28M
佔總股份比例：4.45%。